Skip to content

Urokinase

Kinlytic (urokinase) is an enzyme pharmaceutical. Urokinase was first approved as Kinlytic on 1978-01-16. It is used to treat coronary thrombosis, myocardial infarction, pulmonary embolism, vascular graft occlusion, and venous thrombosis in the USA.
Trade Name Kinlytic
Common Name Urokinase
Indication coronary thrombosis, myocardial infarction, pulmonary embolism, vascular graft occlusion, venous thrombosis
Drug Class Enzymes
Urokinase
Get full access now